# Trade Mark Journal No.2026/004 23 January 2026

## WO0000001895555 (5)

Office of origin: United States of America

Date of International Registration:13 November 2025
Date of designation in the UK: 13 November 2025

The mark consists of a stylized human figure, with a magenta circle centered between two vertical bent lines representing the figure's arms in magenta and its legs in purple.

The mark contains the colours magenta and purple.

The mark consists of a stylized human figure, with a magenta circle centered between two vertical bent lines representing the figure's arms in magenta and its legs in purple.

International priority date claimed: 15 May 2025 (United States of America) (99187857)

Class 5
  Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating endocrine disorders and endocrine-related diseases; pharmaceutical preparations for the treatment of acromegaly, carcinoid syndrome, neuroendocrine tumors, and cancer; all for human use.

Crinetics Pharmaceuticals, Inc.

Representative: Danny Awdeh FINNEGAN HENDERSON FARABOW GARRETT & DUNNER, LLP, 901 New York Avenue, NW, Suite 800, Washington DC 20001, UNITED STATES OF AMERICA